CIS Pharma Christmas event at Palazzo Colombino

Basel, Switzerland, Friday, December 8, 2017 - We spend the night at Palazzo Colombino, a Variété that offers a night with delishes food and spectacular artistic performances. The exquisite dishes [...]

CIS Pharma verified compatibility of its polymer-drug carriers to be used in antibody-drug conjugates and antibody-radionuclid conjugates

Bubendorf, Switzerland, Monday, October 16, 2017 - The polymer experts from CIS Pharma successfully accomplished a first proof-of-concept study on the compatibility of their polymer-drug carriers with a conjugation technique [...]

CIS Pharma summer event in Alsace

Strasbourg, France, Thursday, July 20, 2017 - The CIS Pharma Summer Event takes us to Alsace, France. Our first stop is well known in France and abroad for its foie [...]

CIS Pharma presenting ADC drug carrier technology at Swiss Biotech Day 2017

Basel, Switzerland, Thursday, May 4, 2017 - CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma [...]

CIS Pharma starts R&D project by SNI for 3D printed biocompatible membranes for tissue regeneration

Bubendorf, Switzerland, Wednesday, April 26, 2017 - The Swiss Nanoscience Institute has granted CIS Pharma funding for an innovative project in the field of implantology. The Project is a collaboration [...]

CIS Pharma appoints Dr. Christophe Thommen as new head of research and laboratory operations

Bubendorf, Switzerland, Thursday, December 1, 2016 - CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is [...]

CIS Pharma to launch new web presence

Bubendorf, Switzerland, Monday, August 1, 2016 - CIS Pharma’s new company website is online. The site was established in collaboration with SKYWEB, a fast-growing start-up incorporated in close proximity to [...]

Approval received for intracameral cefuroxime for antibiotic prophylaxis of endophthalmitis after cataract surgery

Uppsala, Sweden, Mai 24, 2016 – The marketing authorization application for intracameral cefuroxime has been finalized with a positive outcome. The decentralized procedure was led by Sweden as reference member [...]

Development of vial adaptor for preparation of intracameral cefuroxime

Bubendorf, April 10, 2016 – CIS Pharma enters agreement with West Pharma to develop a vial adaptor specific for the preparation and injection of intracameral cefuroxime. The development is innovative [...]

Submission of marketing authorization application for intracameral cefuroxime completed

Uppsala, Sweden, July 20, 2015 – CIS Pharma has submitted to the Swedish competent authority MPA the marketing authorization application for intracameral cefuroxime. The decentralized procedure is led by Sweden [...]